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Key points: Risk of SARS-CoV-2 transmission within households is very high. Enforcing protective 
measures at home during COVID-19 episodes, as well as supporting self-isolation within the house 




























Research on SARS-CoV-2 transmission within households and other close settings using serological 
testing is scarce. 
Methods 
We invited COVID-19 cases diagnosed between February 27 and April 1, 2020, in canton of Vaud, 
Switzerland, to participate, along with household members and other close contacts. Anti-SARS-CoV-
2 IgG antibodies were measured using a Luminex immunoassay. We estimated factors associated 
with serological status using generalized estimating equations. 
Results 
Overall, 219 cases, 302 household members, and 69 other close contacts participated between May 
4 and June 27, 2020. More than half of household members (57.2%, 95%CI 49.7-64.3) had developed 
a serologic response to SARS-CoV-2, while 19.0% (95%CI 10.0-33.2) of other close contacts were 
seropositive. After adjusting for individual and household characteristics, infection risk was higher in 
household members aged 65 or more than in younger adults (aOR 3.63, 95%CI 1.05-12.60), and in 
those not strictly adhering to simple hygiene rules like hand washing (aOR 1.80, 95%CI 1.02-3.17). 
The risk was lower when more than 5 people outside home were met during semi-confinement, 
compared to none (aOR 0.35, 95%CI 0.16-0.74). Individual risk of household members to be 























During semi-confinement, household members of a COVID-19 case were at very high risk of getting 
infected, 3 times more than close contacts outside home. This highlights the need to provide clear 
messages on protective measures applicable at home. For elderly couples, who were especially at 
risk, providing external support for daily basic activities is essential. 
 
























The understanding of transmission patterns is especially critical to guide interventions aiming at 
limiting the occurrence of new cases of coronavirus disease 2019 (COVID-19). In this respect, 
transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in promiscuous 
settings such as households is of particular interest and is at the core of the early investigation 
protocols provided by the World Health Organization (WHO Unity Studies) to address the many 
unknowns related to the COVID-19 pandemic 1,2. 
Studies dealing with the transmission of SARS-CoV-2 within households have found secondary attack 
rates (SAR) ranging from 3.9 to 44.6%, reflecting heterogeneous settings and study designs 3. The 
evidence regarding transmission to close contacts outside the household tends to show lower SAR 
(from 0.7 to 5.1%), but attack rates above 50% have been reported in certain circumstances 4–8. Most 
studies conducted so far are based on the identification of active disease through nucleic acid 
amplification tests (NAAT), whose sensitivity can be hampered by various factors 9. 
The availability of serological assays allows the identification of past infection and thus provides key 
input into our understanding of the epidemiology of SARS-CoV-2. Nevertheless, studies on SARS-
CoV-2 transmission in close settings using serological testing remain scarce. So far, most of them 
found SAR close to 35% within households 10–13. However, none of them includes a thorough 
investigation of factors associated with seropositivity. Regarding close contacts outside the 
household, research shows SAR ranging from 0 to 13.7%, but study designs and settings are 
disparate 12,14–16. Furthermore, the amount of available serological assays is quickly growing, often 
with limited external validation of their accuracy, and concerns are emerging regarding their 
accuracy in the setting of seroepidemiological studies because of the lower median level of 





















This work was part of SerocoViD, a community-based seroepidemiological study of SARS-CoV-2 
infection conducted in canton of Vaud, Switzerland, embedded within a nationwide program, 
Corona Immunitas 18. Taking advantage of prior development and validation of a highly sensitive 
serological assay carried out locally 19, the objective was to determine the prevalence of anti-SARS-
CoV-2 IgG antibodies among household members and other close contacts of COVID-19 cases, and 
to identify factors associated with seropositivity in these highly exposed people. 
 
Methods 
Study design and participants 
SerocoViD is a cross-sectional community-based seroepidemiological study of SARS-CoV-2 infection 
conducted in canton of Vaud (French-speaking region of Switzerland, 806’088 inhabitants on 
December 31, 2019). The study was launched at the end of April 2020, coinciding with the easing of 
semi-confinement measures taken in Switzerland in mid-March. From February 27 (first confirmed 
case in canton of Vaud) to March 4, 2020, all COVID-19 cases underwent contact tracing by local 
authorities. At that time, a close contact was any individual who had been within two meters of an 
infected person for at least 15 minutes, starting 24 hours before illness onset. Given the exponential 
growth of the number of cases, contact tracing was stopped from week 2 of the epidemic. For the 
same reason, from March 9, 2020, diagnostic testing was limited to healthcare personal, hospitalized 
people and individuals at increased risk for severe illness in the entire country. 
We sampled confirmed COVID-19 cases from the cantonal registry (total n≈3’700). With the 
exception of three people (one deceased, two who returned home abroad), all confirmed cases from 
week 1 were invited to participate in the study (n=13), along with their close contacts identified by 
contact tracing (n=117). Additionally, all cases aged between 6 months and 19 years (n=66) and a 





















during weeks 2 to 5 (from March 5 to April 1, 2020) were invited to take part in the study. In order to 
extend the age range of confirmed cases for whom a contact tracing procedure had been 
performed, the study team conducted complementary tracing procedures for three adolescent 
cases, thus identifying 20 additional close contacts outside the household. 
Overall, this resulted in the solicitation of 447 confirmed cases (called thereafter index cases) and 
137 close contacts not belonging to the household of index cases. Moreover, index case participants 
were asked to invite all their household members aged 6 months or more to take part in the study. 
Because of testing restrictions, index cases were not necessarily the first infected in their household, 
but those fulfilling testing criteria. All index cases were diagnosed using NAAT. 
Patient consent statement 
The Cantonal Ethics Committee of Vaud, Switzerland, approved the protocol (ID 2020-00887), and 
written consent was obtained from participants. 
Procedures 
Index cases and their close contacts identified by contact tracing were invited by letters. Participants 
registered into the study and answered the study questionnaire (available in French and English) via 
an online platform. The questionnaire covered the following topics: socio-demographic information, 
medical history, history of symptoms compatible with COVID-19 and use of health services, living 
conditions and household characteristics, contacts with other people in private and professional 
settings, and compliance with measures aimed at controlling the epidemic. The full questionnaire is 
available as supplementary material. 
Study visits took place in four centers distributed over the cantonal territory between May 4 and 
June 27, 2020. A venous blood sample was collected to proceed with serological testing. We offered 
a home visit by a mobile study team to people at increased risk for severe illness from COVID-19. All 





















Detection of anti-SARS-CoV-2 antibodies 
We measured anti-SARS-CoV-2 IgG antibodies targeting the spike (S) protein in its native trimeric 
form using a Luminex immunoassay. This test was developed by the Lausanne University Hospital, 
Switzerland, in collaboration with the École Polytechnique Fédérale de Lausanne (EPFL), and 
compared with five commercially available immunoassays detecting IgG against the N protein and 
the monomeric moieties of the S1 protein 19. The in-house Luminex S protein trimer IgG assay was 
99.2% specific in sera from people infected with pre-pandemic coronaviruses or from patients 
with autoimmune diseases, and proved to be more sensitive (96.7%) than commercial tests in 
hospitalized patients with moderate to severe disease 16 to 33 days post-symptoms. The threshold 
for a positive result was defined at an antibody Multiplex Fluorescent Immunoassay (MFI) ratio of 
≥6. 
Statistical analysis 
We calculated the proportion of index cases with a positive serology test result and computed a 
Clopper-Pearson 95% confidence interval (95%CI). Significant clustering of infections within 
households has been reported in previous research 20. In order to account for correlation between 
close contacts of a same index case, we used generalized estimating equations (GEE) with an 
exchangeable correlation structure to estimate the seroprevalence and corresponding 95%CI among 
contacts. Odds ratios (OR) were computed to measure the strength of the association between each 
independent variable and serology test result. We used GEE to account for correlation between 
contacts of a same index case and calculated OR with their 95%CI and p-value using a logit link 
function. Finally, a multivariable regression model using GEE was fitted to measure the adjusted 
association of individual and household characteristics with serology test result among household 
members. Considering the potential influence of past diagnostic testing for SARS-CoV-2 on the 





















previous nasal or throat swabbing. We performed statistical analysis using Stata/IC version 16.1. 
There was no imputation of missing values. 
Results 
Two-hundred and nineteen index cases (49.0%), aged 2 to 90 years (mean 48.7, SD 19.3), 
participated in the study, of which 55.7% considered themselves as women. They reported 421 
household members, of which 302 (71.7%), aged 1 to 87 years (mean 37.0, SD 21.3), took part in the 
study. Sixty-nine (50.4%) close contacts outside the household, aged 9 to 85 years (mean 47.8, SD 
17.0), participated. 
Prevalence of seropositivity in the different groups 
Most index cases (215/219, 98.2%) had a positive serological test result (95%CI 95.4-99.5; figure 1). 
The crude proportion of positives was 53.0% in household members (160/302) and 17.4% among 
close contacts outside the household (12/69). When taking into account correlation, the 
seroprevalence was 57.2% in household members (95%CI 49.7-64.3) and 19.0% in close contacts 
outside the household (95%CI 10.0-33.2). 
Unadjusted association of individual and household characteristics with seropositivity (bivariable 
analysis) 
A higher proportion of household members aged 65 to 75 (85.7%) and 75 or more (83.3%) were 
seropositive (table 1). No association between serological test result and gender or level of 
education was found (figure 2). Household members currently smoking had lower odds of infection 
than non-smokers in bivariable analysis (unadjusted OR 0.56, 95%CI 0.32-0.96). In close contacts 
outside the household, seroprevalence was 30.3% and 5.7% in overweight/obese and 
normal/underweight participants, respectively, but no association was found in household 





















infection (table 2, figure 2). We found no association between serology and the compliance with 
social distancing rules. Positive test results were less frequent in household members who had met 
more than five people per week during the semi-confinement compared to none (unadjusted OR 
0.42, 95%CI 0.22-0.78), but there was no association with the number of close encounters with 
symptomatic individuals. In bivariable analysis, seroprevalence significantly decreased with 
increasing household size. We found that 66.1% of participants living with one other person only 
(the index COVID-19 case) had a positive test result, contrasting with participants living with five 
people or more, who showed a 26.0% risk to be seropositive (unadjusted OR 0.19, 95%CI 0.06-0.62). 
There was an inverse relationship between household size and mean age of participants in the 
household (supplementary table 1). 
Adjusted association of individual and household characteristics with seropositivity (multivariable 
analysis) 
We finally estimated the adjusted association of individual and household characteristics with 
serology test result among household members (table 3). The odds of infection were almost four 
times higher in household members aged 65 or more than in the younger age group (adjusted OR 
3.63, 95%CI 1.05-12.60). The association of current smoking with negative serology observed in 
bivariable analysis faded in multivariable model (adjusted OR 0.73, 95%CI 0.38-1.39). Although 
overweight/obesity tended to be associated with higher odds of infection, this association was not 
statistically significant at the 0.05 level. In comparison with bivariable analysis, we observed a 
strengthening of the relation between the absence of strict adherence to simple hygiene rules and 
positive serology testing (adjusted OR 1.80, 95%CI 1.02-3.17). However, there was no indication of a 
link with adherence to social distancing rules or mask wearing. The association of a greater number 
of social contacts during the semi-confinement with lower odds of infection was confirmed in 
multivariable analysis (adjusted OR 0.35, 95%CI 0.16-0.74). On the other hand, close encounters with 





















statistically significant at the 0.05 level. Household characteristics did not show a significant 
association with serological test result. Adding characteristics of the index case to the model (age, 
gender) yielded comparable estimates (results not shown). 
Prevalence and clinical presentation of flu-like episodes, and use of health services 
The occurrence of one flu-like episode or more since the end of February 2020 was strongly 
associated with positive serological testing, both in household members (OR 3.55, 95%CI 2.37-5.32, 
table 4) and close contacts outside the household (OR 8.64, 95%CI 1.77-42.12). The proportion of 
asymptomatic seropositive individuals (i.e. not reporting any flu-like episode) was 21.4% in 
household members, and 16.7% in close contacts outside the household. With the exception of 
chest pain, all reported symptoms were associated with a positive serology. This was particularly 
evident in household members mentioning new-onset anosmia or ageusia, of which 92.8% were 
seropositive (OR 6.24, 95%CI 3.46-11.24). When limiting the analysis to participants not reporting 
previous nasal or throat swabbing, the strength of the association between symptoms and serology 
generally increased (supplementary table 2). Half the seropositive household members not 
mentioning prior PCR testing reported tiredness (49.6%; figure 3), followed by headache (44.1%), 
cough (37.1%), fever (36.8%), aching muscle or joints (36.6%), and anosmia or ageusia (35.9%). 
Gastrointestinal symptoms were infrequent. Half of seropositive household members (46.3%) 
reported contact with a medical provider, and 6.3% were hospitalized. Figures were comparable 
among seropositive close contacts outside the household (41.7% and 8.3%, respectively). However, 
hospitalization rate was higher in index cases (14.7%). 
Discussion 
More than one in two participants living with a confirmed COVID-19 case has developed a serologic 
response to SARS-CoV-2, while one in five close contacts outside the household was seropositive. 





















we observed is substantially higher than the one reported in previous seroepidemiological studies, 
including a large nationwide survey conducted in Spain (37.4%), and a retrospective cohort study 
conducted in Singapore (11%, estimation based on Bayesian modelling) 11–13,23. One study disclosed a 
SAR of 80% in household members of essential workers, but estimation was based on 30 participants 
only 10. Beside serological testing characteristics, differences could be due to variable average 
household sizes (2.2 members in Switzerland vs 2.6 in Spain) 24, unequal adoption of protective 
behaviors within households 25, or different levels of confinement. Regarding close contacts outside 
the household, previous seroepidemiological studies provided SAR estimations ranging from 0 to 
13.7% 12,14–16,23. Heterogeneity of results could reflect different study designs and settings, and 
varying adherence to public health protective recommendations 25. The strong difference observed 
between the prevalence in household members and in close contacts outside home is probably due 
the fact that contacts at home are closer and last longer than outside, due to the difficulty of 
applying social distancing in limited spaces and with family members. Moreover, simple hygiene 
rules may be more neglected at home, maybe due to a feeling of security. 
We found that older household members were at particularly high risk, corroborating the findings of 
previous research on transmission using NAAT 8,26,27. This association was not found for close 
contacts outside home. This suggests that elderly couples are even less able to apply protective 
measures at home, due to their high level of mutual dependency. There was no difference in 
infection susceptibility according to gender, which is in line with other works 5,23,26. The impact of 
smoking on the risk of SARS-CoV-2 infection is a controversial issue 28. Although household members 
currently smoking were less frequently positive, this association vanished in multivariable analysis, 
suggesting that it may be confounded by other factors. The importance of hygiene measures to 
avoid transmission within household is confirmed by our observations 29. Mask wearing in public and 
respect of social distancing rules, which is particularly difficult when living under the same roof, were 
not associated with infection risk in households. In contrast, the association of a greater number of 





















took place during a period of semi-confinement, during which most people stayed at home, except 
those who had to go out to work in essential sectors. Our findings thus show that the individual risk 
of being infected is higher when staying at home than working outside, the aim of confinement (or 
quarantine) being to break the transmission chain. We have thus to accept that this works well but 
at the price of a higher risk for household members of COVID-19 cases to be infected. Like previous 
studies, we found an inverse relationship between household size and the proportion of seropositive 
household members 26,27. This seems counter-intuitive, as prevalence of infectious diseases is well 
known to be associated with crowded housing. However, being many in a household allows 
decreasing mutual dependency and thus close contacts. This association was weakened by inclusion 
of the mean age of household members in the multivariable model, suggesting that the apparent 
protective effect of a high number of household members could reflect the fact that large families 
are, on average younger. However, disentangling respective contributions of household size and age 
distribution of household members remains difficult. 
Regarding the clinical presentation of COVID-19, the proportion of asymptomatic seropositive 
individuals was close to findings of Pollán and colleagues in Spain (28.5%) 12. Even if not specific, a 
large number of symptoms were still associated with SARS-CoV-2 infection, especially new-onset 
smell and/or taste disturbance, confirming the clinical utility of this symptom to suspect COVID-19 30. 
Interestingly, the prevalence of flu-like symptoms was high also in seronegative people, maybe 
because the first epidemic wave occurred just after the winter, when other respiratory infections 
were still quite prevalent. 
Limitations need to be acknowledged. The Swiss testing policy during the first epidemic wave, which 
limited diagnostic testing mainly to individuals at increased risk for severe illness, made the sample 
of index cases not representative of all cases that occurred in the community during this period. 





















criteria. However, this would be especially problematic if the purpose were to identify factors 
associated with infectivity of the index case, which we deliberately avoided. 
Incidence of new COVID-19 cases remains high worldwide and prevention of transmission is, for 
now, the only way to tackle the pandemic. If concerns regarding the transmission of SARS-CoV-2 in 
shops, restaurants and public gatherings are justified, our findings emphasize that the risk of being 
infected is much higher at home. However, this remains overlooked in collective awareness and 
public health discourse, precisely because quarantine and confinement are methods used to break 
the transmission chain. Early testing of the first case in a household is important to support 
immediate self-isolation within the house. Our results suggest in particular that it is essential for 
non-institutionalized elderly couples to receive strong external support for daily basic needs during 
the infectious period of the index case. Further research is needed to determine the efficacy and 
acceptability of specific measures aimed at limiting SARS-CoV-2 transmission within households and 
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Household members (N=302) Close contacts outside the household (N=69) 
  n (%) seropositive n (%) seropositive 
Unadjusted OR 
[95% CI] p-value n (%) seropositive 
Unadjusted OR 
[95% CI] p-value 





Age     
 
0.119   
 
0.928 
6mo-<5y 1/2 (50.0) 5/11 (45.5) 0.92 [0.37-2.29] 
 
no participant ··   
5y-<10y 1/1 (100.0) 12/22 (54.6) 1.16 [0.55-2.44] 
 
0/1 (0.0) ··   
10y-<15y 2/2 (100.0) 15/32 (46.9) 0.93 [0.49-1.75] 
 
0/3 (0.0) ··   
15y-<20y 20/21 (95.2) 9/19 (47.4) 1.17 [0.56-2.45] 
 
0/2 (0.0) ··   
20y-<40y 42/43 (97.7) 37/76 (48.7) reference 
 
3/15 (20.0) reference   
40y-<65y 103/104 (99.0) 60/116 (51.7) 0.83 [0.52-1.30] 
 
7/38 (18.4) 0.92 [0.22-3.87]   
65y-<75y 31/31 (100.0) 12/14 (85.7) 3.98 [1.03-15.44] 
 
2/9 (22.2) 1.32 [0.16-11.00]   
75y or more 15/15 (100.0) 10/12 (83.3) 5.25 [1.16-23.72] 
 
0/1 (0.0) ··   
Gender     
 
0.164   
 
0.124 
male 94/96 (97.9) 74/146 (50.7) reference 
 
8/30 (26.7) reference   
female 120/122 (98.4) 86/156 (55.1) 1.27 [0.91-1.76] 
 
4/39 (10.3) 0.36 [0.10-1.32]   
other 1/1 (100.0) no participant ·· 
 
no participant ··   
Current smoker 1     
 
0.034   
 
0.825 
no 191/194 (98.5) 142/256 (55.5) reference 
 
10/59 (17.0) reference   
yes 23/24 (95.8) 18/46 (39.1) 0.56 [0.32-0.96] 
 
2/9 (22.2) 1.21 [0.22-6.53]   
Weight status     
 
0.146   
 
0.011 
normal or underweight 104/106 (98.1) 92/184 (50.0) reference 
 
2/35 (5.7) reference   
overweight or obese 110/112 (98.2) 66/111 (59.5) 1.37 [0.90-2.09] 
 
10/33 (30.3) 6.74 [1.54-29.50]   
        





Education     
 
0.196   
 
0.423 
lower secondary or less 21/21 (100.0) 21/33 (63.6) reference 
 
3/10 (30.0) reference   
upper secondary 58/59 (98.3) 46/82 (56.1) 0.93 [0.46-1.90] 
 
5/23 (21.7) 0.64 [0.13-3.21]   
tertiary 108/109 (99.1) 51/100 (51.0) 0.61 [0.30-1.24] 
 
4/30 (13.3) 0.33 [0.06-1.83]   
Chronic medical conditions 2     
 
0.037   
 
0.148 
none 131/133 (98.5) 86/169 (50.9) reference 
 
6/44 (13.6) reference   
one or more 58/58 (100.0) 32/47 (68.1) 1.94 [1.04-3.62] 
 
6/19 (31.6) 2.48 [0.73-8.48]   
Hypertension     
 
0.110   
 
0.034 
no 152/154 (98.7) 95/182 (52.2) reference 
 
7/50 (14.0) reference   
yes 36/36 (100.0) 21/31 (67.7) 1.81 [0.87-3.74] 
 
5/11 (45.5) 4.48 [1.12-18.01]   
Diabetes     
 
0.489   
 
0.082 
no 169/171 (98.8) 111/206 (53.9) reference 
 
10/57 (17.5) reference   
yes 15/15 (100.0) 4/6 (66.7) 1.75 [0.36-8.48] 
 
2/3 (66.7) 8.59 [0.76-96.92]   
Cardiovascular disease     
 
0.239   
 
·· 
no 170/172 (98.8) 103/196 (52.6) reference 
 
12/58 (20.7) ··   
yes 12/12 (100.0) 9/12 (75.0) 2.03 [0.62-6.62] 
 
0/2 (0.0) ··   
Kidney disease     
 
··   
 
·· 
no 181/183 (98.9) 115/212 (54.3) ·· 
 
12/60 (20.0) ··   
yes 3/3 (100.0) no participant ·· 
 
0/1 (0.0) ··   
Chronic respiratory disease     
 
0.196   
 
·· 
no 177/179 (98.9) 106/202 (52.5) reference 
 
12/59 (20.3) ··   
yes 7/7 (100.0) 4/5 (80.0) 3.79 [0.50-28.52] 
 
0/2 (0.0) ··   
Immunodeficiency     
 
0.596   
 
·· 
no 174/176 (98.9) 110/202 (54.5) reference 
 
12/58 (20.7) ··   
yes 12/12 (100.0) 4/9 (44.4) 0.74 [0.25-2.23] 
 
0/3 (0.0) ··   
Cancer     
 
··   
 
·· 
no 177/179 (98.9) 113/209 (54.1) ·· 
 
12/58 (20.7) ··   
yes 4/4 (100.0) no participant ·· 
 
0/2 (0.0) ··   
Other chronic condition     
 
0.325   
 
·· 
no 159/160 (99.4) 97/184 (52.7) reference 
 
12/55 (21.8) ··   
yes 24/25 (96.0) 18/28 (64.3) 1.49 [0.68-3.27] 
 
0/7 (0.0) ··   
 
Calculation of odds ratio and p-value: correlation between close contacts of a same index case taken into account using GEE (exchangeable correlation structure, logit link 






















Table 2: Serology test result according to adherence to measures aimed at decreasing transmission, contacts with other people, and living conditions, stratified by type 
of participant (unadjusted results) 
 
Household members (N=302) Close contacts outside the household (N=69) 
  n (%) seropositive 
Unadjusted OR 
[95% CI] p-value n (%) seropositive 
Unadjusted OR 
[95% CI] p-value 
Respect of measures and contacts with other people   
 
    
  Respect of simple hygiene rules (washing hands regularly, sneezing 
into the elbow, etc.)   
 
0.123   
 
0.272 
yes 114/215 (53.0) reference   8/56 (14.3) reference 
 rather yes 40/74 (54.1) 1.46 [0.97-2.20]   4/13 (30.8) 2.22 [0.54-9.21] 
 rather no or no 4/9 (44.4) 2.08 [0.63-6.87]   no participant ·· 
        
Respect of social distancing rules (physical distancing, avoid 
shaking hands or kissing, etc.)   
 
0.868   
 
0.114 
yes 87/157 (55.4) reference   7/53 (13.2) reference 
 rather yes 56/105 (53.3) 0.99 [0.64-1.52]   5/15 (33.3) 2.94 [0.77-11.23] 
 rather no or no 15/36 (41.7) 0.77 [0.42-1.43]   0/1 (0.0) ·· 
        
Wearing a mask in public   
 
0.657   
 
0.093 
no 79/163 (48.5) reference   5/38 (13.2) reference 
 yes, sometimes 54/98 (55.1) 1.15 [0.75-1.74]   2/17 (11.8) 1.06 [0.21-5.35] 
 yes, always 27/40 (67.5) 1.31 [0.70-2.45]   5/13 (38.5) 4.36 [1.06-17.83] 
 Weekly number of people met outside home during the semi-
confinement   
 
0.009   
 
0.761 
none 65/100 (65.0) reference   2/17 (11.8) reference 
 1 to 5 73/140 (52.1) 0.87 [0.53-1.43]   6/34 (17.7) 1.26 [0.25-6.35] 
 more than 5 21/61 (34.4) 0.42 [0.22-0.78]   4/17 (23.5) 1.86 [0.32-10.75] 
 Close contact with people outside home having symptoms 
suggestive of COVID-19   
 
0.456   
 
0.099 
none 127/233 (54.5) reference   2/14 (14.3) reference 
 1 person 17/34 (50.0) 1.48 [0.80-2.75]   5/42 (11.9) 0.88 [0.15-5.01] 
 2 people or more 16/35 (45.7) 1.11 [0.63-1.96]   5/12 (41.7) 4.36 [0.68-27.99] 
 Living conditions and household characteristics 1   
 
    
  Housing type 2   
 
0.946   
  individual house 83/158 (52.5) reference     
  apartment, studio or other 77/144 (53.5) 0.98 [0.54-1.79]     
         
         
  Number of people in the household 2   
 
0.046   
  2 39/59 (66.1) reference     
  3 31/51 (60.8) 0.82 [0.35-1.93]     
  4 44/74 (59.5) 0.78 [0.34-1.77]     
  5 33/68 (48.5) 0.43 [0.17-1.06]     
  6 or more 13/50 (26.0) 0.19 [0.06-0.62]     
  Number of habitable rooms (besides kitchen) in the dwelling 3   
 
0.441   
  3 or less 35/54 (64.8) reference     
  4 to 6 96/183 (52.5) 0.67 [0.32-1.40]     
  7 or more 29/65 (44.6) 0.55 [0.21-1.47]     
   
All participants, including children and teens. Calculation of odds ratio and p-value: correlation between close contacts of a same index case taken into account using GEE 
(exchangeable correlation structure, logit link function). 1 Not relevant for close contacts outside the household. 2 Answer of the index case taken for all household 
members. 3Answer of the index case taken for all household members, except two households where information from index case was missing (mean of answers reported 






















Table 3: Adjusted association of individual and household characteristics with serology test result among household members 
  Adjusted OR [95% CI] p-value 
Characteristics of household member   
 Age (ref: 20y-<65y)   
 6mo-<20y 0.92 [0.54-1.59] 0.775 
65y or more 3.63 [1.05-12.60] 0.042 
Gender (ref: male)   
 female 1.37 [0.90-2.08] 0.137 
Current smoker 1 (ref: no)   
 yes 0.73 [0.38-1.39] 0.339 
Weight status (ref: normal or underweight)   
 overweight or obese 1.48 [0.90-2.43] 0.125 
Respect of simple hygiene rules (washing hands regularly, sneezing into the elbow, etc.) (ref: yes)   
 rather yes, rather no, or no 1.80 [1.02-3.17] 0.041 
Respect of social distancing rules (physical distancing, avoid shaking hands or kissing, etc.) (ref: yes)   
 rather yes, rather no, or no 1.06 [0.62-1.82] 0.831 
Wearing a mask in public (ref: no)   
 yes, sometimes 1.02 [0.61-1.72] 0.926 
yes, always 0.94 [0.43-2.09] 0.885 
Weekly number of people met outside home during the semi-confinement (ref: 0)   
 1 to 5 0.70 [0.40-1.21] 0.201 
more than 5 0.35 [0.16-0.74] 0.006 
Close contact with people outside home having symptoms suggestive of COVID-19 (ref: none)   
 1 person 1.29 [0.62-2.67] 0.495 
2 people or more 1.72 [0.86-3.45] 0.125 
Characteristics of household   
 
Highest education level among adult household members (ref: lower secondary or less)   
 upper secondary 1.08 [0.21-5.54] 0.922 
tertiary 1.64 [0.34-7.95] 0.541 
Housing type 2 (ref: individual house)   
 apartment, studio or other 0.87 [0.39-1.95] 0.738 
Number of people in the household 2   
 one-person increase 0.78 [0.56-1.08] 0.135 
Number of habitable rooms (besides kitchen) in the dwelling 3   
 one-room increase 0.98 [0.76-1.25] 0.843 
Mean age of participating household members 4   
 one-year increase 1.00 [0.97-1.04] 0.793 
 
Multivariable regression model; 291/302 household members included in model. Within-household correlation taken into account using GEE (exchangeable correlation 
structure, logit link function). The variable “chronic medical conditions”, that was not available for children and teens, was not included in the model. 1 Children aged less 
than 12 considered non-smokers. 2 Answer of the index case taken for all household members. 3 Answer of the index case taken for all household members, except two 
households where information from index case was missing (mean of answers reported by other household members taken instead). 4 Given the association between 


























Household members (N=302) Close contacts outside the household (N=69) 
  n (%) seropositive n (%) seropositive Odds ratio [95% CI] p-value n (%) seropositive Odds ratio [95% CI] p-value 
Symptoms     
  
  
  Flu-like episodes     
 
0.000   
 
0.008 
none 25/26 (96.2) 34/117 (29.1) reference 
 
2/39 (5.1) reference 
 one or more 190/193 (98.5) 125/184 (67.9) 3.55 [2.37-5.32] 
 
10/29 (34.5) 8.64 [1.77-42.12] 
 Cough     
 
0.001   
 
0.003 
no 58/58 (100.0) 84/192 (43.8) reference 
 
5/53 (9.4) reference 
 yes 157/161 (97.5) 76/110 (69.1) 2.07 [1.36-3.15] 
 
7/16 (43.8) 7.76 [2.02-29.84] 
 Runny or stuffy nose, sneezing     
 
0.001   
 
0.008 
no 105/107 (98.1) 93/208 (44.7) reference 
 
5/52 (9.6) reference 
 yes 110/112 (98.2) 67/94 (71.3) 2.18 [1.38-3.44] 
 
7/17 (41.2) 6.33 [1.64-24.46] 
 Sore throat     
 
0.049   
 
0.729 
no 137/140 (97.9) 109/224 (48.7) reference 
 
8/52 (15.4) reference 
 yes 78/79 (98.7) 51/78 (65.4) 1.53 [1.00-2.33] 
 
4/17 (23.5) 1.27 [0.33-4.84] 
 Dyspnea     
 
0.000   
 
0.203 
no 123/125 (98.4) 108/235 (46.0) reference 
 
9/61 (14.8) reference 
 yes 92/94 (97.9) 52/67 (77.6) 2.86 [1.74-4.70] 
 
3/8 (37.5) 2.82 [0.57-13.97] 
 Feeling of fever     
 
0.000   
 
0.901 
no 93/95 (97.9) 87/206 (42.2) reference 
 
9/54 (16.7) reference 
 yes 122/124 (98.4) 73/96 (76.0) 2.74 [1.71-4.40] 
 
3/15 (20.0) 1.09 [0.27-4.44] 
 Temperature 37.5°C or more (measured)     
 
0.000   
 
0.007 
no 80/82 (97.6) 82/209 (39.2) reference 
 
8/63 (12.7) reference 
 yes 135/137 (98.5) 78/93 (83.9) 4.64 [2.82-7.65] 
 
4/6 (66.7) 12.61 [1.98-80.32] 
 Headache     
 
0.000   
 
0.001 
no 79/81 (97.5) 76/180 (42.2) reference 
 
4/52 (7.7) reference 
 yes 136/138 (98.6) 84/122 (68.9) 2.14 [1.43-3.19] 
 
8/17 (47.1) 10.29 [2.55-41.62] 
 Pain in muscles, joints     
 
0.000   
 
0.940 
no 86/89 (96.6) 88/203 (43.4) reference 
 
10/58 (17.2) reference 
 yes 129/130 (99.2) 72/99 (72.7) 2.44 [1.61-3.70] 
 
2/11 (18.2) 0.94 [0.18-4.84] 
 Chest pain     
 
0.444   
 
0.018 
no 150/152 (98.7) 131/258 (50.8) reference 
 
7/58 (12.1) reference 
 yes 65/67 (97.0) 29/44 (65.9) 1.23 [0.72-2.09] 
 
5/11 (45.5) 5.56 [1.34-23.07] 
 Tiredness, exhaustion     
 
0.000   
 
0.001 
no 31/33 (93.9) 62/162 (38.3) reference 
 
3/49 (6.1) reference 
 yes 184/186 (98.9) 98/140 (70.0) 2.66 [1.79-3.95] 
 
9/20 (45.0) 11.03 [2.64-45.97] 
 Appetite loss     
 
0.000   
 
0.003 
no 89/93 (95.7) 104/237 (43.9) reference 
 
7/61 (11.5) reference 
 yes 126/126 (100.0) 56/65 (86.2) 4.52 [2.50-8.17] 
 
5/8 (62.5) 11.30 [2.28-55.89] 
 Nausea, vomiting     
 
0.004   
 
0.181 
no 178/182 (97.8) 138/275 (50.2) reference 
 
11/67 (16.4) reference 
 yes 37/37 (100.0) 22/27 (81.5) 2.93 [1.40-6.13] 
 
1/2 (50.0) 6.51 [0.42-101.56] 
 Diarrhea     
 
0.001   
 
0.475 
no 154/157 (98.1) 123/250 (49.2) reference 
 
10/62 (16.1) reference 
 yes 61/62 (98.4) 37/52 (71.2) 2.37 [1.41-3.99] 
 
2/7 (28.6) 1.90 [0.33-11.00] 
 Belly pain     
 
0.002   
 
0.530 
no 175/178 (98.3) 134/267 (50.2) reference 
 
10/62 (16.1) reference 
 yes 40/41 (97.6) 26/35 (74.3) 2.76 [1.44-5.28] 
 
2/7 (28.6) 1.75 [0.31-10.01] 
 Sudden loss of smell or taste     
 
0.000   
 
0.001 
no 74/77 (96.1) 96/233 (41.2) reference 
 
6/62 (9.7) reference 
 yes 141/142 (99.3) 64/69 (92.8) 6.24 [3.46-11.24] 
 
6/7 (85.7) 65.25 [5.47-779.10] 





















Table 4: continued 
Index cases 
(N=219) 
Household members (N=302) Close contacts outside the household (N=69) 
  n (%) seropositive n (%) seropositive Odds ratio [95% CI] p-value n (%) seropositive Odds ratio [95% CI] p-value 
Use of health services     
  
  
  Contact with a medical provider     
 
0.000   
 
0.027 
no 28/28 (100.0) 86/209 (41.2) reference 
 
7/57 (12.3) reference 
 yes 185/189 (97.9) 74/93 (79.6) 3.61 [2.19-5.95] 
 
5/12 (41.7) 4.62 [1.20-17.86] 
 Nasal or throat swabbing to detect SARS-CoV-2     
 
0.000   
 
0.002 
no ·· (1) 110/240 (45.8) reference 
 
7/63 (11.1) reference 
 yes ·· (1) 50/62 (80.7) 2.74 [1.61-4.65] 
 
5/6 (83.3) 38.52 [3.95-375.53] 




··   
 
·· 
negative or unknown ·· (1) 5/16 (31.3) ·· 
 
4/5 (80.0) ·· 
 positive ·· (1) 45/46 (97.8) ·· 
 
1/1 (100.0) ·· 
 Hospitalization     
 
0.028   
 
·· 
no 181/185 (97.8) 150/291 (51.6) reference 
 
11/68 (16.2) ·· 
 yes 32/32 (100.0) 10/11 (90.9) 4.96 [1.19-20.62] 
 
1/1 (100.0) ·· 
 Admission to the ICU     
 
··   
 
·· 
no 203/207 (98.1) 158/300 (52.7) ··   12/69 (17.4) ·· 
 yes 10/10 (100.0) 2/2 (100.0) ··   no participant ·· 
 Intubation     
 
··   
 
·· 
no 210/214 (98.1) 160/302 (53.0) ··   12/69 (17.4) ·· 
 yes 3/3 (100.0) no participant ··   no participant ·· 
  
All participants, including children and teens. Calculation of odds ratio and p-value: correlation between close contacts of a same index case taken into account using GEE 






















Figure 1: Percentage of participants with a positive serology test result, by type of participant 
 
Index cases: crude proportion, calculation of 95% confidence interval using the Clopper-Pearson 
method. Household members and close contacts outside the household: proportion and 
corresponding 95% confidence interval estimated using GEE (exchangeable correlation structure). 


































Figure 2: Unadjusted association between characteristics of household members of index cases and seropositivity (bivariable analysis)
 
Calculation of odds ratio: correlation between household members of a same index case taken into account using GEE (exchangeable correlation structure, 






















Figure 3: Percentage of household members reporting specific symptoms, according to serology 
test result 
 
Household members not reporting prior nasal or throat swabbing to detect SARS-CoV-2. Correlation 
between household members of a same index case taken into account using GEE (exchangeable 
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